ALB - Albemarle Corp Stock Analysis
Albemarle Corp (ALB) is a publicly traded company listed on the NYSE. It operates in the Specialty Chemicals industry, part of the broader Basic Materials sector. The company has a market capitalization of 14.02B, generates annual revenue of 4.95B, and reports net income of -187.91M. As of the latest data, the stock is trading at 119.14 USD.
From a valuation and risk perspective, the stock presents the following profile: The P/E ratio is unavailable or not meaningful at this time. The PEG ratio is below 1, which may indicate the stock is undervalued relative to its growth potential. The company maintains a healthy balance between debt and equity, which is typical for stable businesses. The dividend yield (1.36%) is modest, often associated with growth-oriented companies. The stock exhibits higher volatility than the market, which may indicate greater risk and potential reward.
Analyst recommendation stands at Hold (3.35), indicating current market sentiment. Institutional ownership is reported at 93.43%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 7.04%, trading within a 52-week range of 49.43 - 132.90.
ALB - Albemarle Corp
119.14
Analyst Consensus
Hold 3.35
ALB – Analyst Rating Summary
- Strong Buy: 4
- Buy: 7
- Hold: 17
- Sell: 2
- Strong Sell: 1
- Total Analysts: 31
| Index: | S&P 500 | P/E: | - | EPS (ttm): | -1.60 | Insider Own: | 0.67% | Shs Outstand: | 117.69M | Perf Week: | -6.12% |
| Market Cap: | 14.02B | Forward P/E: | 118.47 | EPS next Y: | 1.01 | Insider Trans: | -0.04% | Shs Float: | 116.91M | Perf Month: | 34.70% |
| Income(ttm): | -187.91M | PEG: | - | EPS next Q: | -0.67 | Inst Own: | 93.43% | Short Float: | 9.28% | Perf Quarter: | 46.11% |
| Revenue(ttm): | 4.95B | P/S: | 2.83 | EPS this Y: | 63.13% | Inst Trans: | -4.85% | Short Ratio: | 2.86 | Perf Half Y: | 103.17% |
| Book/sh: | 65.94 | P/B: | 1.81 | EPS next Y: | 216.55% | ROA: | -0.12% | Short Interest: | 10.85M | Perf Year: | 7.04% |
| Cash/sh: | 16.41 | P/C: | 7.26 | EPS next 5Y: | - | ROE: | -0.21% | 52W Range: | 49.43 - 132.90 | Perf YTD: | 38.41% |
| Dividend Est.: | 1.62 (1.36%) | P/FCF: | 134.43 | EPS past 3/5Y: | - - | ROIC: | -1.41% | 52W High: | 132.90 -10.35% | Beta: | 1.42 |
| Dividend TTM: | 1.62 (1.36%) | Quick Ratio: | 1.51 | Sales past 3/5Y: | 17.35% 8.42% | Gross Margin: | 12.27% | 52W Low: | 49.43 141.03% | Perf 5Y: | -13.45% |
| Dividend Ex-Date: | Dec 12, 2025 | Current Ratio: | 2.27 | EPS Y/Y TTM: | 90.47% | Oper. Margin: | 0.51% | RSI (14): | 55.89 | Volatility: | 3.98% 5.54% |
| Employees: | 8300 | Debt/Eq: | 0.38 | Sales Y/Y TTM: | -23.92% | Profit Margin: | -3.80% | Recom: | 2.56 | Target Price: | 107.95 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.33 | EPS Q/Q: | 81.80% | Payout: | - | Rel Volume: | 1.12 | Prev Close: | 126.49 |
| Sales Surprise: | 2.44% | EPS Surprise: | 77.95% | Sales Q/Q: | -3.46% | Earnings: | Nov 05 AMC | Avg Volume: | 3.79M | Price: | 119.14 |
| SMA20: | 2.09% | SMA50: | 16.34% | SMA200: | 53.55% | Overbought: 9.39% | Volume: | 4,227,337 | Change: | -5.81% | |
Graham Classic formula value: -12.21
(P/E=8 * 1g) Min value: -11.49
(current P/E * 2g) Max value: -0.0
Average value: -7.9
About Albemarle Corp
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, Ketjen, and All Other. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The All Other segment refers only to the FCS business that did not fit into any of the company's core businesses. The company was founded in 1993 and is headquartered in Charlotte, NC.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.